当科での研修について

次世代の大腸外科を背負う人材を育成する

診療科としての人材育成のポイント

総年間大腸癌手術件数は 600 例以上という豊富な症例数の環境下、手術内容も変化に富み、腹腔鏡・ロボット手術などの縮小・低侵襲から、隣接・転移臓器合併切除などの拡大手術までを執刀医あるいは助手として経験することができます。近年の多様化した個別化医療時代において、その治療効果を最大化させるためには、我々外科医は多くの引き出しを持ち、それぞれにおいて自らの技術・経験値を高めておく必要があると考えます。1つのアプローチしかできないでは、外科医ではなく単なる技術屋でしかありません。我々は、患者さんのあらゆる状況に責任を持つ医師、外科医でなければいけません。当科でのレジデント終了時には、大腸外科医として必要なすべての基本的な技術を身につけることが可能です。

国立がん研究センター中央病院大腸外科グループでの研修の特徴

日本の大腸悪性腫瘍診療をリードする指導医の直接指導
日本のがん診療の中枢を担う施設での豊富な臨床経験
Surgical Oncologistの育成
フレキシブルに選択可能な研修コースと充実したカリキュラム
関連部門との連携から理想的なdecision makingを学ぶ

数字で見る大腸外科

充実した研究指導の成果としての多数の英文論文

（最近5年間、研修者がfirst authorの論文のみ)

1.Tanaka M, Kanemitsu Y, Shida D, Ochiai H, Tsukamoto S, Nagino M, Moriya Y. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer. Dis Colon Rectum. 2017 Aug;60(8):827-836.

2.Tanaka M, Kanemitsu Y, Ueno H, Kobayashi H, Konishi T, Ishida F, Yamaguchi T, Hinoi T, Inoue Y, Tomita N, Ishida H, Sugihara K. Prognostic impact of hospital volume on familial adenomatous polyposis: a nationwide multicenter study. Int J Colorectal Dis. 2017 Oct;32(10):1489-1498.

3.Yamada K, Tsukamoto S, Ochiai H, Shida D, Kanemitsu Y. Improving Selection for Resection of Synchronous Para-Aortic Lymph Node Metastases in Colorectal Cancer. Dig Surg. 2018 Jul 25:1-7.

4.Tanabe T, Shida D, Tsukamoto S, Morizono G, Taniguchi H, Kanemitsu Y. Metachronous metastasis to inguinal lymph nodes from sigmoid colon adenocarcinoma with abdominal wall metastasis: a case report. BMC Cancer. 2019 Feb 27;19(1):180.

5.Nakamura Y, Shida D, Shibayama T, Yoshida A, Matsui Y, Shinoda Y, Iwata S,Kanemitsu Y. Giant multilocular prostatic cystadenoma. World J Surg Oncol. 2019 Feb 26;17(1):42.

6.Yoshida T, Shida D, Taniguchi H, Tsukamoto S, Kanemitsu Y. Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced Colorectal Cancer with Regarding to the Extent of Bladder Invasion. Ann Surg Oncol. 2019 May;26(5):1569-1576.

7.Komono A, Shida D, Iinuma G, Tsukamoto S, Sakamoto R, Moritani K, Miyake M, Kanemitsu Y. Preoperative T staging of colon cancer using CT colonography with multiplanar reconstruction: new diagnostic criteria based on "bordering vessels".Int J Colorectal Dis. 2019 Apr;34(4):641-648.

8.Imaizumi J, Shida D, Narita Y, Miyakita Y, Tanabe T, Takashima A, Boku N, Igaki H, Itami J, Kanemitsu Y. Prognostic factors of brain metastases from colorectal cancer. BMC Cancer. 2019 Jul 31;19(1):755.

9.Tanabe T, Shida D, Komukai S, Nakamura Y, Tsukamoto S, Kanemitsu Y. Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma. BMC Cancer. 2019 Jul 24;19(1):733.

10.Ahiko Y, Shida D, Horie T, Tanabe T, Takamizawa Y, Sakamoto R, Moritani K, Tsukamoto S, Kanemitsu Y. Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer. BMC Cancer. 2019 Nov 6;19(1):946.

11.Komono A, Shida D, Iinuma G, Tsukamoto S, Sakamoto R, Moritani K, Miyake M, Kanemitsu Y. Preoperative T staging of colon cancer using CT colonography with multiplanar reconstruction: new diagnostic criteria based on "bordering vessels".Int J Colorectal Dis. 2019 34(4):641-648

12.Ahiko Y, Shida D, Horie T, Tanabe T, Takamizawa Y, Sakamoto R, Moritani K, Tsukamoto S, Kanemitsu Y. Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer. BMC Cancer. 2019 6;19(1):946.

13.Nakamura Y, Shida D, Tanabe T, Takamizawa Y, Imaizumi J, Ahiko Y, Sakamoto R, Moritani K, Tsukamoto S, Kanemitsu Y. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer. Cancer Med. 2020 9(2):653-662.

14.Mazaki J, Tsukamoto S, Miyake M, Moritani K, Sakamoto R, Shida D, Kanemitsu Y. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy. Dis Colon Rectum. 2021 Jan;64(1):71-80.

15.Takamizawa Y, Shida D, Boku N, Nakamura Y, Ahiko Y, Yoshida T, Tanabe T, Takashima A, Kanemitsu Y. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer. BMC Cancer. 2020 Nov 11;20(1):1092.

16.Yasui K, Shida D, Nakamura Y, Ahiko Y, Tsukamoto S, Kanemitsu Y.Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients. Br J Cancer. 2021 Mar;124(5):933-941.

17.Horie T, Shida D, Ahiko Y, Takamizawa Y, Inoue M, Tanabe T, Nakamura Y,Imaizumi J, Tsukamoto S, Kanemitsu Y. Laparoscopic versus Open Colectomy for Elderly Patients with Colon Cancer: A Propensity Score Analysis with the Controlling Nutritional Status (CONUT) Score. Nutr Cancer. 2021;73(2):246-251.

18.Tanabe T, Shida D, Boku N, Yoshida T, Tsukamoto S, Takashima A, Kanemitsu Y. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis. Dis Colon Rectum. 2021 Sep 1;64(9):1074-1082.

19.Ahiko Y, Shida D, Nakamura Y, Imaizumi J, Takamizawa Y, Moritani K, Tsukamoto S, Kanemitsu Y. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer. Dis Colon Rectum. 2021 Oct 1;64(10):1222-1231.

20.Nakamura Y, Shida D, Boku N, Yoshida T, Tanabe T, Takamizawa Y, Takashima A,Kanemitsu Y. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer. Dis Colon Rectum. 2021 Nov 1;64(11):1331-1341.

21.Kudose Y, Shida D, Ahiko Y, Nakamura Y, Sakamoto R, Moritani K, Tsukamoto S,Kanemitsu Y. Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort. Ann Surg. 2022 Apr 1;275(4):727-734